Somewhat Positive Press Coverage Somewhat Unlikely to Affect CounterPath (CPAH) Share Price

News articles about CounterPath (NASDAQ:CPAH) (TSE:CCV) have trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. CounterPath earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave press coverage about the software maker an impact score of 44.8360135358415 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

CPAH has been the subject of a number of analyst reports. ValuEngine raised CounterPath from a “sell” rating to a “hold” rating in a report on Tuesday, August 8th. Zacks Investment Research raised CounterPath from a “sell” rating to a “hold” rating in a report on Wednesday, September 13th.

CounterPath (NASDAQ:CPAH) opened at $2.16 on Wednesday. CounterPath has a 1-year low of $1.75 and a 1-year high of $3.00.

TRADEMARK VIOLATION NOTICE: This piece was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at

About CounterPath

CounterPath Corporation designs, develops and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol (IP)-based networks.

Insider Buying and Selling by Quarter for CounterPath (NASDAQ:CPAH)

Receive News & Ratings for CounterPath Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CounterPath Corporation and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply